美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
82497-017-04	82497-017	HUMAN PRESCRIPTION DRUG	Otrexup	methotrexate	INJECTION, SOLUTION	SUBCUTANEOUS	20240925	N/A	NDA	NDA204824	Otter Pharmaceuticals, LLC	METHOTREXATE	17.5 mg/.4mL	4 SYRINGE in 1 CARTON (82497-017-04) / .4 mL in 1 SYRINGE (82497-017-02)
54436-010-01	54436-010	HUMAN PRESCRIPTION DRUG	Otrexup	methotrexate	INJECTION, SOLUTION	SUBCUTANEOUS	20131011	20270430	NDA	NDA204824	Antares Pharma, Inc.	METHOTREXATE	10 mg/.4mL	1 SYRINGE in 1 CARTON (54436-010-01) / .4 mL in 1 SYRINGE
54436-010-03	54436-010	HUMAN PRESCRIPTION DRUG	Otrexup	methotrexate	INJECTION, SOLUTION	SUBCUTANEOUS	20131011	20270430	NDA	NDA204824	Antares Pharma, Inc.	METHOTREXATE	10 mg/.4mL	1 SYRINGE in 1 CARTON (54436-010-03) / .4 mL in 1 SYRINGE
54436-010-04	54436-010	HUMAN PRESCRIPTION DRUG	Otrexup	methotrexate	INJECTION, SOLUTION	SUBCUTANEOUS	20131011	20270430	NDA	NDA204824	Antares Pharma, Inc.	METHOTREXATE	10 mg/.4mL	4 SYRINGE in 1 CARTON (54436-010-04) / .4 mL in 1 SYRINGE (54436-010-02)
54436-020-01	54436-020	HUMAN PRESCRIPTION DRUG	Otrexup	methotrexate	INJECTION, SOLUTION	SUBCUTANEOUS	20131011	20270430	NDA	NDA204824	Antares Pharma, Inc.	METHOTREXATE	20 mg/.4mL	1 SYRINGE in 1 CARTON (54436-020-01) / .4 mL in 1 SYRINGE
54436-020-03	54436-020	HUMAN PRESCRIPTION DRUG	Otrexup	methotrexate	INJECTION, SOLUTION	SUBCUTANEOUS	20131011	20270430	NDA	NDA204824	Antares Pharma, Inc.	METHOTREXATE	20 mg/.4mL	1 SYRINGE in 1 CARTON (54436-020-03) / .4 mL in 1 SYRINGE
54436-020-04	54436-020	HUMAN PRESCRIPTION DRUG	Otrexup	methotrexate	INJECTION, SOLUTION	SUBCUTANEOUS	20131011	20270430	NDA	NDA204824	Antares Pharma, Inc.	METHOTREXATE	20 mg/.4mL	4 SYRINGE in 1 CARTON (54436-020-04) / .4 mL in 1 SYRINGE (54436-020-02)
82497-010-04	82497-010	HUMAN PRESCRIPTION DRUG	Otrexup	methotrexate	INJECTION, SOLUTION	SUBCUTANEOUS	20240925	N/A	NDA	NDA204824	Otter Pharmaceuticals, LLC	METHOTREXATE	10 mg/.4mL	4 SYRINGE in 1 CARTON (82497-010-04) / .4 mL in 1 SYRINGE (82497-010-02)
82497-020-04	82497-020	HUMAN PRESCRIPTION DRUG	Otrexup	methotrexate	INJECTION, SOLUTION	SUBCUTANEOUS	20240925	N/A	NDA	NDA204824	Otter Pharmaceuticals, LLC	METHOTREXATE	20 mg/.4mL	4 SYRINGE in 1 CARTON (82497-020-04) / .4 mL in 1 SYRINGE (82497-020-02)
54436-012-01	54436-012	HUMAN PRESCRIPTION DRUG	Otrexup	methotrexate	INJECTION, SOLUTION	SUBCUTANEOUS	20160324	20270430	NDA	NDA204824	Antares Pharma, Inc.	METHOTREXATE	12.5 mg/.4mL	1 SYRINGE in 1 CARTON (54436-012-01) / .4 mL in 1 SYRINGE
54436-012-03	54436-012	HUMAN PRESCRIPTION DRUG	Otrexup	methotrexate	INJECTION, SOLUTION	SUBCUTANEOUS	20160324	20270430	NDA	NDA204824	Antares Pharma, Inc.	METHOTREXATE	12.5 mg/.4mL	1 SYRINGE in 1 CARTON (54436-012-03) / .4 mL in 1 SYRINGE
54436-012-04	54436-012	HUMAN PRESCRIPTION DRUG	Otrexup	methotrexate	INJECTION, SOLUTION	SUBCUTANEOUS	20160324	20270430	NDA	NDA204824	Antares Pharma, Inc.	METHOTREXATE	12.5 mg/.4mL	4 SYRINGE in 1 CARTON (54436-012-04) / .4 mL in 1 SYRINGE (54436-012-02)
54436-022-01	54436-022	HUMAN PRESCRIPTION DRUG	Otrexup	methotrexate	INJECTION, SOLUTION	SUBCUTANEOUS	20160324	20270430	NDA	NDA204824	Antares Pharma, Inc.	METHOTREXATE	22.5 mg/.4mL	1 SYRINGE in 1 CARTON (54436-022-01) / .4 mL in 1 SYRINGE
54436-022-03	54436-022	HUMAN PRESCRIPTION DRUG	Otrexup	methotrexate	INJECTION, SOLUTION	SUBCUTANEOUS	20160324	20270430	NDA	NDA204824	Antares Pharma, Inc.	METHOTREXATE	22.5 mg/.4mL	1 SYRINGE in 1 CARTON (54436-022-03) / .4 mL in 1 SYRINGE
54436-022-04	54436-022	HUMAN PRESCRIPTION DRUG	Otrexup	methotrexate	INJECTION, SOLUTION	SUBCUTANEOUS	20160324	20270430	NDA	NDA204824	Antares Pharma, Inc.	METHOTREXATE	22.5 mg/.4mL	4 SYRINGE in 1 CARTON (54436-022-04) / .4 mL in 1 SYRINGE (54436-022-02)
82497-015-04	82497-015	HUMAN PRESCRIPTION DRUG	Otrexup	methotrexate	INJECTION, SOLUTION	SUBCUTANEOUS	20240925	N/A	NDA	NDA204824	Otter Pharmaceuticals, LLC	METHOTREXATE	15 mg/.4mL	4 SYRINGE in 1 CARTON (82497-015-04) / .4 mL in 1 SYRINGE (82497-015-02)
82497-025-04	82497-025	HUMAN PRESCRIPTION DRUG	Otrexup	methotrexate	INJECTION, SOLUTION	SUBCUTANEOUS	20240925	N/A	NDA	NDA204824	Otter Pharmaceuticals, LLC	METHOTREXATE	25 mg/.4mL	4 SYRINGE in 1 CARTON (82497-025-04) / .4 mL in 1 SYRINGE (82497-025-02)
54436-017-01	54436-017	HUMAN PRESCRIPTION DRUG	Otrexup	methotrexate	INJECTION, SOLUTION	SUBCUTANEOUS	20160324	20270430	NDA	NDA204824	Antares Pharma, Inc.	METHOTREXATE	17.5 mg/.4mL	1 SYRINGE in 1 CARTON (54436-017-01) / .4 mL in 1 SYRINGE
54436-017-03	54436-017	HUMAN PRESCRIPTION DRUG	Otrexup	methotrexate	INJECTION, SOLUTION	SUBCUTANEOUS	20160324	20270430	NDA	NDA204824	Antares Pharma, Inc.	METHOTREXATE	17.5 mg/.4mL	1 SYRINGE in 1 CARTON (54436-017-03) / .4 mL in 1 SYRINGE
54436-017-04	54436-017	HUMAN PRESCRIPTION DRUG	Otrexup	methotrexate	INJECTION, SOLUTION	SUBCUTANEOUS	20160324	20270430	NDA	NDA204824	Antares Pharma, Inc.	METHOTREXATE	17.5 mg/.4mL	4 SYRINGE in 1 CARTON (54436-017-04) / .4 mL in 1 SYRINGE (54436-017-02)